17-65528964-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004655.4(AXIN2):​c.*1012T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.523 in 271,810 control chromosomes in the GnomAD database, including 40,021 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 20369 hom., cov: 33)
Exomes 𝑓: 0.56 ( 19652 hom. )

Consequence

AXIN2
NM_004655.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.00700

Publications

27 publications found
Variant links:
Genes affected
AXIN2 (HGNC:904): (axin 2) The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008]
AXIN2 Gene-Disease associations (from GenCC):
  • oligodontia-cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • tooth agenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AXIN2NM_004655.4 linkc.*1012T>A 3_prime_UTR_variant Exon 11 of 11 ENST00000307078.10 NP_004646.3 Q9Y2T1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AXIN2ENST00000307078.10 linkc.*1012T>A 3_prime_UTR_variant Exon 11 of 11 1 NM_004655.4 ENSP00000302625.5 Q9Y2T1
AXIN2ENST00000618960.4 linkc.*1012T>A 3_prime_UTR_variant Exon 10 of 10 5 ENSP00000478916.1 E7ES00

Frequencies

GnomAD3 genomes
AF:
0.494
AC:
75020
AN:
151986
Hom.:
20367
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.724
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.666
Gnomad EAS
AF:
0.363
Gnomad SAS
AF:
0.565
Gnomad FIN
AF:
0.592
Gnomad MID
AF:
0.557
Gnomad NFE
AF:
0.607
Gnomad OTH
AF:
0.515
GnomAD4 exome
AF:
0.561
AC:
67134
AN:
119706
Hom.:
19652
Cov.:
0
AF XY:
0.564
AC XY:
32911
AN XY:
58306
show subpopulations
African (AFR)
AF:
0.250
AC:
1051
AN:
4208
American (AMR)
AF:
0.551
AC:
2007
AN:
3642
Ashkenazi Jewish (ASJ)
AF:
0.657
AC:
3952
AN:
6016
East Asian (EAS)
AF:
0.376
AC:
4504
AN:
11988
South Asian (SAS)
AF:
0.557
AC:
3260
AN:
5852
European-Finnish (FIN)
AF:
0.569
AC:
1198
AN:
2106
Middle Eastern (MID)
AF:
0.522
AC:
396
AN:
758
European-Non Finnish (NFE)
AF:
0.601
AC:
45737
AN:
76144
Other (OTH)
AF:
0.559
AC:
5029
AN:
8992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1488
2976
4464
5952
7440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.493
AC:
75023
AN:
152104
Hom.:
20369
Cov.:
33
AF XY:
0.493
AC XY:
36650
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.253
AC:
10499
AN:
41500
American (AMR)
AF:
0.536
AC:
8189
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.666
AC:
2312
AN:
3472
East Asian (EAS)
AF:
0.365
AC:
1887
AN:
5176
South Asian (SAS)
AF:
0.566
AC:
2728
AN:
4822
European-Finnish (FIN)
AF:
0.592
AC:
6252
AN:
10558
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.607
AC:
41263
AN:
67972
Other (OTH)
AF:
0.509
AC:
1074
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1773
3546
5319
7092
8865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.418
Hom.:
1255
Bravo
AF:
0.481
Asia WGS
AF:
0.422
AC:
1470
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Oligodontia-cancer predisposition syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.49
DANN
Benign
0.66
PhyloP100
-0.0070
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7591; hg19: chr17-63525082; API